×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
×
Close
CN1699 Our Business - Guide for Agents
分类
Immunology
19516
Global Medical University
3622
Allergy
1540
Anatomy & Morphology
1308
Andrology
414
Anesthesia & Intensive Care
900
Anesthesiology
4061
Audiology & Speech-Language Pathology
300
Behavioral Sciences
80
Biochemical Research Methods
5017
Biochemistry & Molecular Biology
23518
Biodiversity Conservation
213
Biology
6085
Biophysics
5568
Biotechnology & Applied Microbiology
6250
Cardiac & Cardiovascular Systems
24425
Cardiovascular & Respiratory Systems
1137
Cell & Tissue Engineering
503
Cell Biology
9133
Chemistry, Analytical
3579
Chemistry, Applied
8869
Chemistry, Medicinal
7093
Chemistry, Multidisciplinary
15638
Clinical Immunology & Infectious Disease
342
Clinical Medicine
7678
Clinical Neurology
12717
Clinical Psychology & Psychiatry
783
Critical Care Medicine
2294
Dentistry, Oral Surgery & Medicine
9981
Dermatology
6895
Developmental Biology
5884
Ecology
610
Education, Scientific Disciplines
1415
Emergency Medicine
3002
Endocrinology, Metabolism & Nutrition
18194
Engineering, Biomedical
2860
Entomology
316
Environmental Medicine & Public Health
3553
Evolutionary Biology
192
Gastroenterology & Hepatology
9129
General & Internal Medicine
5340
Genetics & Heredity
11516
Geriatrics & Gerontology
3998
Gerontology
260
Health Care Sciences & Services
11924
Health Policy & Services
472
Hematology
4517
Infectious Diseases
10729
Integrative & Complementary Medicine
1896
Medical Ethics
825
Medical Informatics
1536
Medical Laboratory Technology
429
Medicine, General & Internal
36371
Medicine, Legal
314
Medicine, Research & Experimental
13342
Microbiology
17818
Mycology
0
Nanoscience & Nanotechnology
3918
Neuroimaging
939
Neurology
3289
Neurosciences
30127
Nursing
7363
Nutrition & Dietetics
6904
Obstetrics & Gynecology
6314
Oncology
41419
Ophthalmology
7156
Optics
2918
Orthopedics
8665
Orthopedics, Rehabilitation & Sports Medicine
1235
Otolaryngology
1247
Otorhinolaryngology
3996
Parasitology
761
Pathology
3784
Pediatrics
16408
Peripheral Vascular Disease
3598
Pharmacology & Pharmacy
25267
Pharmacology/Toxicology
9813
Physiology
7411
Polymer Science
424
Primary Health Care
633
Psychiatry
14154
Psychology
4069
Psychology, Applied
65
Psychology, Biological
241
Psychology, Clinical
598
Psychology, Developmental
176
Psychology, Educational
89
Psychology, Experimental
85
Psychology, Mathematical
0
Psychology, Multidisciplinary
1293
Psychology, Psychoanalysis
41
Psychology, Social
78
Public Health & Health Care Science
1868
Public, Environmental & Occupational Health
21947
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
9166
Radiology, Nuclear Medicine & Medical Imaging
6351
Rehabilitation
2516
Remote Sensing
0
Reproductive Biology
1957
Reproductive Medicine
851
Research/Laboratory Medicine & Medical Technology
2881
Respiratory System
5463
Rheumatology
4344
Social Sciences, Biomedical
1015
Substance Abuse
2139
Surgery
25199
Toxicology
3522
Transplantation
775
Tropical Medicine
274
Urology & Nephrology
9834
Veterinary Sciences
35
Virology
1840
Zoology
0
渠道
IMMUNOTHERAPY
34
AIDS
478
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
74
BIODRUGS
103
CANCER IMMUNOLOGY RESEARCH
99
CELLULAR & MOLECULAR IMMUNOLOGY
276
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
72
CLINICAL IMMUNOLOGY
0
CURRENT OPINION IN IMMUNOLOGY
144
EUROPEAN JOURNAL OF IMMUNOLOGY
170
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
2973
FRONTIERS IN IMMUNOLOGY
6668
IMMUNOLOGICAL REVIEWS
81
IMMUNOLOGY
96
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
941
JOURNAL OF AUTOIMMUNITY
204
JOURNAL OF CLINICAL IMMUNOLOGY
374
JOURNAL OF EXPERIMENTAL MEDICINE
100
JOURNAL OF IMMUNOLOGY
683
JOURNAL OF INNATE IMMUNITY
89
JOURNAL OF LEUKOCYTE BIOLOGY
180
JOURNAL OF NEUROINFLAMMATION
454
LANCET HIV
25
MUCOSAL IMMUNOLOGY
161
NATURE IMMUNOLOGY
453
NATURE REVIEWS IMMUNOLOGY
286
SEMINARS IN IMMUNOLOGY
140
VACCINE
0
VACCINES
1933
WORLD ALLERGY ORGANIZATION JOURNAL
0
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY
210
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
97
EUROPEAN JOURNAL OF INFLAMMATION
67
HUMAN IMMUNOLOGY
1
IMMUNITY INFLAMMATION AND DISEASE
125
IMMUNOLOGY LETTERS
0
IRANIAN JOURNAL OF IMMUNOLOGY
91
JOURNAL OF INFLAMMATION RESEARCH
966
JOURNAL OF INFLAMMATION-LONDON
48
MICROBIOLOGY AND IMMUNOLOGY
46
SCANDINAVIAN JOURNAL OF IMMUNOLOGY
76
IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY
128
ANTIBODIES
97
AUTOIMMUNITY HIGHLIGHTS
5
LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS
26
IMMUNOLOGIC RESEARCH
180
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
62
SCI时时刷
search
全部
推荐
+
Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review
Hypophysitis is rarely reported in patients receiving pembrolizumab-only immunotherapies. Since the clinical presentation ...
Immunotherapy
comment
0
thumb_up
0
Atherosclerosis: immunopathogenesis and strategies for immunotherapy
Atherosclerosis, a chronic inflammatory condition in which atheroma accumulates within the intima of the arterial wall, is...
Immunotherapy
comment
0
thumb_up
0
Anti-PD-1 and regorafenib induce severe multisystem adverse events in microsatellite stability metastatic colorectal cancer: a case report
There exists a dilemma in the treatment of microsatellite stability (MSS) metastatic colorectal cancer (mCRC) owing to lim...
Immunotherapy
comment
0
thumb_up
0
Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair deficient pancreatic cancer
Mismatch repair protein deficiency occurs in 0.8–2% of pancreatic ductal adenocarcinomas and confers susceptibility to imm...
Immunotherapy
comment
0
thumb_up
0
Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer
Aim: We report real-world treatment patterns and outcomes in patients with PD-L1+ non-small cell lung cancer (NSCLC). Meth...
Immunotherapy
comment
0
thumb_up
0
Patient needs and benefits of sublingual immunotherapy for grass pollen-induced allergic rhinitis: an observational study
Aim: Clinical efficacy of sublingual immunotherapy for grass pollen-induced allergic rhinitis (AR) needs to translate into...
Immunotherapy
comment
0
thumb_up
0
Pretreatment lung immune prognostic index as a biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumab
Background: To investigate the role of pretreatment lung immune prognostic index (LIPI) as biomarker in PD-L1 ≥50% non-sma...
Immunotherapy
comment
0
thumb_up
0
Delayed cytokine release syndrome after neoadjuvant nivolumab: a case report and literature review
Aim: Cytokine release syndrome (CRS) is an infrequently described immune-related adverse event of checkpoint inhibitors (C...
Immunotherapy
comment
0
thumb_up
0
Chemotherapy or chemo-immunotherapy as first-line treatment for extensive-stage small-cell lung cancer – a meta-analysis
This meta-analysis investigated the clinical benefits of chemo-immunotherapy in extensive-stage small-cell lung cancer (ES...
Immunotherapy
comment
0
thumb_up
0
Durable complete remission of leptomeningeal melanoma by intrathecal methotrexate maintained with systemic ipilimumab
Leptomeningeal disease (LMD) is a complication of metastasized melanoma, with poor prognosis even in the era of immunother...
Immunotherapy
comment
0
thumb_up
0
Enteric plexus neuropathy associated with PD-L1 blockade in a patient with small-cell lung cancer
Immune checkpoint inhibitors have revolutionized the management of patients with cancer. The increasing use of these agent...
Immunotherapy
comment
0
thumb_up
0
TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases
JAKs are intracellular protein tyrosine kinases that, through activation of STATs, are responsible for signal transduction...
Immunotherapy
comment
0
thumb_up
0
Volume increase of spleen in melanoma patients undergoing immune checkpoint blockade
Aim: To find out whether treatment with immune checkpoint inhibitors (ICIs) results in volume increase of the spleen. Pati...
Immunotherapy
comment
0
thumb_up
0
Immune checkpoint inhibitors for brain metastases in non-small-cell lung cancer: from rationale to clinical application
Brain metastases (BM) is common in non-small-cell lung cancer (NSCLC) patients. Immune checkpoint inhibitors (ICIs) have g...
Immunotherapy
comment
0
thumb_up
0
PD-L1 expression as a predictive biomarker for immune checkpoint inhibitors: between a dream and a nightmare
PD-L1 is an important predictive biomarker for treatment by immune checkpoint inhibitors (ICIs). ICIs are now indicated fo...
Immunotherapy
comment
0
thumb_up
0
Pretreatment lung immune prognostic index as biomarker in advanced non-small-cell lung cancer patients receiving first line pembrolizumab
Background: To investigate the role of pretreatment lung immune prognostic index (LIPI) as biomarker in PD-L1 ≥50% non-sma...
Immunotherapy
comment
0
thumb_up
0
Immunotherapy for cholangiocarcinoma: a 2021 update
Cholangiocarcinoma (CCA) is a rare malignancy with generally dismal prognosis. Immunotherapy has revolutionized the manage...
Immunotherapy
comment
0
thumb_up
0
Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models
Aim: Graft-versus-host disease (GvHD) is a major complication arising in patients undergoing allogenic hematopoietic stem ...
Immunotherapy
comment
0
thumb_up
0
Checkpoint inhibitors in BCG-unresponsive nonmuscle invasive bladder cancer: can they help spare the bladder?
Intravesical BCG therapy has been for years, the standard of care in nonmuscle-invasive bladder cancer. But upon recurrenc...
Immunotherapy
comment
0
thumb_up
0
Urothelial carcinoma in the era of immune checkpoint inhibitors
Bladder cancer is the seventh most frequent cancer worldwide. The majority of patients present with nonmuscle invasive dis...
Immunotherapy
comment
0
thumb_up
0
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report
Abscopal effect has been mentioned for a long time, but only recently a deeper knowledge about underlying mechanisms suppo...
Immunotherapy
comment
0
thumb_up
0
CT-P13 subcutaneous infliximab in gastroenterology and rheumatology
The drug infliximab has been a key milestone in the treatment of inflammatory conditions such as Crohn's disease, ulcerati...
Immunotherapy
comment
0
thumb_up
0
Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma
The use of immune checkpoint inhibitors in patients with metastatic melanoma generates clinical benefit, including improve...
Immunotherapy
comment
0
thumb_up
0
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma
SMARCA4-deficient thoracic sarcoma (DTS) is a recently noted progressive thoracic malignancy. We recently experienced thre...
Immunotherapy
comment
0
thumb_up
0
Real-world study of PD-L1 testing patterns and treatment distribution in patients with metastatic non-small-cell lung cancer in Israel
Aim: We describe PD-L1 testing patterns and first-line treatment for patients with metastatic non-small-cell lung cancer i...
Immunotherapy
comment
0
thumb_up
0
Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological database
Aim: To describe real-world pembrolizumab administration and outcomes for advanced melanoma in France. Materials & met...
Immunotherapy
comment
0
thumb_up
0
Is there a role for immune checkpoint inhibitors in chordoma?
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest...
Immunotherapy
comment
0
thumb_up
0
Chimeric antigen receptor macrophage for glioblastoma immunotherapy: the way forward
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial intere...
Immunotherapy
comment
0
thumb_up
0
Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis
Aim: We aimed to compare the mortality rates related to adverse events (AEs) and discontinuation of treatment due to toxic...
Immunotherapy
comment
0
thumb_up
0
Current landscape of immunotherapy trials in locally advanced and high-risk head and neck cancer
The current standard of therapy for locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) is limited by toxi...
Immunotherapy
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin